[go: up one dir, main page]

MX2018016103A - Metodos para manejar los efectos adversos en poblaciones de pacientes que necesitan una transfusion. - Google Patents

Metodos para manejar los efectos adversos en poblaciones de pacientes que necesitan una transfusion.

Info

Publication number
MX2018016103A
MX2018016103A MX2018016103A MX2018016103A MX2018016103A MX 2018016103 A MX2018016103 A MX 2018016103A MX 2018016103 A MX2018016103 A MX 2018016103A MX 2018016103 A MX2018016103 A MX 2018016103A MX 2018016103 A MX2018016103 A MX 2018016103A
Authority
MX
Mexico
Prior art keywords
adverse events
methods
patient populations
requiring transfusion
transfusion
Prior art date
Application number
MX2018016103A
Other languages
English (en)
Inventor
Cordero Rafael
Keegan Philip
Yoshida Tatsuro
D''alessandro Angelo
Dunham Andrew
Original Assignee
New Health Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New Health Sciences Inc filed Critical New Health Sciences Inc
Publication of MX2018016103A publication Critical patent/MX2018016103A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/38—Removing constituents from donor blood and storing or returning remainder to body, e.g. for transfusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/02—Blood transfusion apparatus
    • A61M1/0272—Apparatus for treatment of blood or blood constituents prior to or for conservation, e.g. freezing, drying or centrifuging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • External Artificial Organs (AREA)

Abstract

Metodo para medicina transfusional para reducir los episodios adversos en poblaciones de pacientes que reciben transfusiones sobre la base de una fisiologia subyacente del paciente.
MX2018016103A 2016-06-23 2017-06-22 Metodos para manejar los efectos adversos en poblaciones de pacientes que necesitan una transfusion. MX2018016103A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662354041P 2016-06-23 2016-06-23
PCT/US2017/038859 WO2017223377A1 (en) 2016-06-23 2017-06-22 Methods for managing adverse events in patient populations requiring transfusion

Publications (1)

Publication Number Publication Date
MX2018016103A true MX2018016103A (es) 2019-05-02

Family

ID=59337864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018016103A MX2018016103A (es) 2016-06-23 2017-06-22 Metodos para manejar los efectos adversos en poblaciones de pacientes que necesitan una transfusion.

Country Status (10)

Country Link
US (4) US20190388467A1 (es)
EP (2) EP3474922A1 (es)
JP (2) JP7053508B2 (es)
CN (2) CN109414542B (es)
AU (3) AU2017281514B2 (es)
BR (1) BR112018076512A2 (es)
CA (1) CA3028435C (es)
IL (4) IL263695B2 (es)
MX (1) MX2018016103A (es)
WO (1) WO2017223377A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3474922A1 (en) * 2016-06-23 2019-05-01 New Health Sciences, Inc. Methods for managing adverse events in patient populations requiring transfusion
EP3708174B1 (en) * 2017-05-19 2022-10-12 Hemanext Inc. Methods and treatment of trauma
US12447177B2 (en) * 2018-11-16 2025-10-21 Hemanext Inc. Methods for managing adverse events in patients with inflammation
IL320256A (en) * 2022-10-20 2025-06-01 Hemanext Inc Treatment of burn patients with hypoxic blood
EP4604975A1 (en) * 2022-10-20 2025-08-27 Hemanext Inc. Treatment of blood transfusion-dependent patients with hematologic malignancies

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6447987B1 (en) 1978-09-09 2002-09-10 The United States Of America As Represented By The Secretary Of The Army Prolonged storage of red blood cells
US4769318A (en) 1986-06-03 1988-09-06 Ube Industries, Ltd. Additive solution for blood preservation and activation
US4880786A (en) 1987-01-14 1989-11-14 Ube Industries, Ltd. Additive solution for blood preservation and activation
US5120659A (en) 1989-06-26 1992-06-09 Mine Safety Appliances Company Deuterated water test method
US5439882A (en) * 1989-12-29 1995-08-08 Texas Tech University Health Sciences Center Blood substitute
US5789152A (en) 1991-04-30 1998-08-04 Basil T. Hone Composition and method for detecting HIV with baculovirus derived vesicles
US5476764A (en) 1994-09-16 1995-12-19 The Regents Of The University Of California Method using CO for extending the useful shelf-life of refrigerated red blood cells
US5624794A (en) 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US6162396A (en) 1997-04-26 2000-12-19 The Regents Of The University Of California Blood storage device and method for oxygen removal
US5789151A (en) 1997-05-15 1998-08-04 The Regents Of The University Of California Prolonged cold storage of red blood cells by oxygen removal and additive usage
US20020159995A1 (en) * 1997-07-30 2002-10-31 Renal Tech International Devices, systems, and methods for reducing levels of pro-inflammatory or anti-inflammatory stimulators or mediators in the blood, generated as a result of extracorporeal blood processing
US6413713B1 (en) 1998-10-30 2002-07-02 Hyperbaric Systems Method for preserving blood platelets
CA2467087A1 (en) 2001-11-16 2003-05-30 Hemanext, Llc Additive solution for blood preservation
EP3789056B9 (en) * 2007-08-31 2025-09-24 SeaStar Medical, Inc. Selective cytopheresis devices
US8430831B2 (en) * 2009-02-25 2013-04-30 The Invention Science Fund I, Llc Device, system, and method for controllably reducing inflammatory mediators in a subject
EP2442641A4 (en) * 2009-06-16 2016-03-09 Univ Columbia METHOD FOR REDUCING SIDE EFFECTS OF THE TRANSFUSION OF AGED RED BLOOD CELLS
US9199016B2 (en) * 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
CN102711865B (zh) * 2009-10-12 2015-08-19 新健康科学股份有限公司 具有氧和二氧化碳消耗能力的血液贮藏袋系统和消耗装置
CA2782311C (en) * 2009-12-01 2017-06-27 Robert S. Ward Method for removing cytokines from blood with surface immobilized polysaccharides
JP2014518283A (ja) * 2011-07-05 2014-07-28 ニュー・ヘルス・サイエンシーズ・インコーポレイテッド 赤血球の長期保存システムおよび使用方法
KR20130015481A (ko) * 2011-08-03 2013-02-14 한양대학교 산학협력단 적혈구의 인 비트로 대량 생산방법 및 이의 저장 방법
WO2013057592A2 (en) * 2011-09-14 2013-04-25 King Abdullah University Of Science And Technology Treatment of sickle cell disease
WO2016172645A1 (en) * 2015-04-23 2016-10-27 New Health Sciences, Inc. Anaerobic blood storage containers
ES3042959T3 (en) * 2015-05-18 2025-11-24 Hemanext Inc Methods for the storage of whole blood, and compositions thereof
EP3474922A1 (en) * 2016-06-23 2019-05-01 New Health Sciences, Inc. Methods for managing adverse events in patient populations requiring transfusion

Also Published As

Publication number Publication date
AU2017281514B2 (en) 2022-11-24
IL323109A (en) 2025-11-01
WO2017223377A1 (en) 2017-12-28
AU2022259846A1 (en) 2022-12-08
EP4321215A2 (en) 2024-02-14
EP3474922A1 (en) 2019-05-01
IL297507B1 (en) 2023-09-01
AU2022259846B2 (en) 2025-01-02
IL263695B (en) 2022-11-01
CN115429961A (zh) 2022-12-06
IL263695B2 (en) 2023-03-01
CA3028435C (en) 2025-09-09
JP2019521998A (ja) 2019-08-08
CA3028435A1 (en) 2017-12-28
EP4321215A3 (en) 2024-04-17
JP7053508B2 (ja) 2022-04-12
BR112018076512A2 (pt) 2019-04-02
IL297507A (en) 2022-12-01
US20230047634A1 (en) 2023-02-16
US20250177440A1 (en) 2025-06-05
US20190388467A1 (en) 2019-12-26
IL263695A (en) 2019-02-28
JP2022093350A (ja) 2022-06-23
IL297507B2 (en) 2024-01-01
CN109414542B (zh) 2022-09-09
US11090331B2 (en) 2021-08-17
JP7267482B2 (ja) 2023-05-01
IL305115A (en) 2023-10-01
US20200276234A1 (en) 2020-09-03
AU2017281514A1 (en) 2019-01-17
CN109414542A (zh) 2019-03-01
AU2024278209A1 (en) 2025-01-02

Similar Documents

Publication Publication Date Title
BR112015017272A2 (pt) sistemas, métodos e aparelho de seleção de entrada agrícola
MX2018016103A (es) Metodos para manejar los efectos adversos en poblaciones de pacientes que necesitan una transfusion.
EP4374814A3 (en) Head-mounted display device for use in a medical facility
WO2014210077A3 (en) Systems and methods for establishing and updating clinical care pathways
CL2016000354A1 (es) Modulación de la inmunidad tumoral
MX367109B (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
MX349731B (es) Gestion de datos microsismicos para equiparacion de fracturas.
MX2015009058A (es) Composiciones y metodos para tratar la inflamacion cronica y las enfermedades inflamatorias.
EP3091461C0 (en) BLOOD DONATION TRACKING DATABASE QUERY PROCESSING SYSTEM
EP3459471A3 (en) Guide wire alignment
TW201613975A (en) Methods for treating multiple myeloma
ZA202503388B (en) Semaglutide in medical therapy
SA517390475B1 (ar) نظام أكياس متعددة وطريقة لتحضير مكونات الدم
NZ717595A (en) Methods and tools relating to the administration of contrast medium
MX2016013449A (es) Hiperestimulacion ovarica controlada con la hormona estimuladora folicular humana recombinante mejorada.
MX2017012449A (es) Tratamiento del dolor.
MA39599A (fr) Dosage et administration d'agents thérapeutiques anti-egfr
MX2019014090A (es) Métodos para el tratamiento de la reservoritis crónica.
EP3148438A4 (en) Systems and methods for managing blood donations
MX2017000118A (es) Biocontrol de enfermedades asociadas a la semilla en plantulas.
TW201614516A (en) Heterogeneous storing server and file storing method thereof
CA3276299A1 (en) Methods for managing adverse events in patient populations requiring transfusion
MX2016013979A (es) Nuevas vias de administracion de insulina, analogos de insulina o derivados de insulina.
UA84302U (ru) Способ коррекции иммунного статуса у больных рекуррентным депрессивным расстройством
UA92326U (ru) Способ коррекции системы антиоксидантной защиты у больных вегетативной дистонией с артериальной гипертензией